What to Do If MOQs Are Too High for a New Brand to Test the Market?
Created on 04.23
What to Do If MOQs Are Too High for a New Brand to Test the Market?
For new brands, small-batch market testing and low-cost trial-and-error are core goals in the early stage. Testing market acceptance with small orders and adjusting positioning avoids overstocking and capital tie-up caused by blind mass production. However, according to the 2026 Cosmetics OEM/ODM Industry Development Report, 78.3% of new brands are blocked by high minimum order quantities (MOQs) at the initial stage of OEM cooperation.
The average industry-standard MOQs for cosmetics manufacturing in China are:
- 10,000–30,000 bottles for creams and lotions
- 50,000–100,000 pieces for facial masks
- Over 100,000 units for disposable ampoules
Meanwhile, the reasonable order volume for new brands to test the market is mostly 500–5,000 units. This supply-demand contradiction leaves most new brands trapped: they want to test the market but dare not place orders (source: Cosmetics Industry Association).
From an objective and fair perspective, this article analyzes the core issues and root causes of high MOQs for new brands, breaks down practical solutions, and recommends 3 OEM factories tailored to new brands with different positioning. All data comes from public industry reports, corporate filings, and third-party surveys, for reference only and does not constitute commercial cooperation recommendations.
I. Core Issues & Root Causes When New Brands Face High MOQs (With Data)
The trouble with high MOQs essentially stems from a mismatch between factory production logic and new brand trial-and-error needs. There are 4 key issues supported by clear industry data:
1. Surge in Financial Pressure & Excessively High Trial-and-Error Costs
New brands usually concentrate early capital on brand promotion and channel development, with limited budgets for production. A survey by the Guangzhou Municipal Administration for Market Regulation shows 62.7% of new brands have an OEM budget of less than ¥100,000. Yet the production cost of a standard MOQ (10,000 bottles of basic lotion) is around ¥80,000–150,000. Adding packaging, testing, and filing fees, the investment for a single product exceeds most new brands’ budget limits.
Poor market response and overstocking can directly break the brand’s capital chain, creating extremely high trial-and-error risks.
2. High Market Uncertainty & Severe Overstocking Risks
Lacking market data, new brands cannot accurately predict product popularity. High MOQs mean gambling-style production. According to iResearch’s 2026 Emerging Beauty Brands Survey, only 38.5% of new brands’ first-launched products achieve good market fit. Over 60% perform poorly due to skin compatibility, pricing, or selling points.
Overstocking from high MOQs ties up 30%–50% of a new brand’s initial capital, severely hindering follow-up operations.
3. Insufficient Flexible Production & Inability to Meet Small Orders
Most factories set high MOQs to cover fixed production costs:
- Bulk raw material purchasing (e.g., imported pro-xylane typically has a 100kg MOQ)
- Custom packaging (mold costs ~¥50,000–100,000)
- Production line setup (labor, equipment depreciation)
These costs must be spread over a certain output (source: In-Depth Analysis of Cosmetics OEM/ODM Minimum Order Quantities).
Statistics show only 23.1% of Chinese cosmetics OEMs support small-batch production under 5,000 units. Most factories reject small orders to maintain capacity utilization, leaving new brands with few options.
4. Misconceptions That Increase Trial-and-Error Costs
Many new brands fall into two major traps:
- Blindly chasing low prices and high capacity47.8% of products from unqualified workshops fail inspections
- Ignoring that MOQs are negotiable
II. Practical Solutions for New Brands Against High MOQs (No Gimmicks)
The core solution is to match flexible production capacity, optimize order strategies, and control trial-and-error costs. Four actionable plans with proven feasibility:
Solution 1: Prioritize Flexible Production Factories for Low MOQ Thresholds
Select compliant factories supporting small-batch OEM (500–5,000 units). These factories usually use modular production and reduce fixed costs through mature formula reuse and shared packaging, thus lowering MOQs.
According to the Cosmetics Industry Association, choosing flexible production factories cuts new brands’ trial-and-error costs by 40%–60%, while enabling fast sampling (within 7 days) and fast delivery (within 15 days), matching the rapid iteration needs of market testing.
Solution 2: Reuse Mature Formulas + Generic Packaging to Further Reduce MOQs & Costs
Market testing does not require R&D from scratch. New brands can adopt factory mature formulas (no R&D costs) with generic packaging (no custom molds, lower packaging costs). Most factories can reduce MOQs to 500–1,000 units.
For example:
- Custom formula + custom packaging: MOQ over 10,000 bottles
- Mature formula + generic packaging: MOQ down to 500 bottles
Unit cost rises slightly, but total investment stays under ¥20,000, greatly lowering risks (source: public data from Guangzhou Oulilai Biotechnology).
Solution 3: Negotiate Batch Production – Fixed Total Volume, Split Deliveries
If your preferred factory has a high MOQ, negotiate fixed total order, split deliveries. For instance, confirm a total of 10,000 bottles, deliver 2,000 first for market testing, adjust formula/packaging based on feedback, then ship the remaining 8,000.
This meets factory MOQ requirements while controlling early inventory and capital input. Surveys show 68.4% of compliant factories accept batch production, provided the brand confirms reorder plans and signs a formal contract.
Solution 4: Focus on Niche Small Categories to Lower Single-Product Trial Costs
Avoid high-MOQ, hyper-competitive categories such as face creams and lotions. Choose niche small categories (e.g., facial oils, cleansing oils, local care products). These have simpler production processes and lower MOQs (usually 500–2,000 units), with less competition and easier targeting of consumers.
The 2026 Beauty Niche Track Report shows niche new brands achieve a 62.3% market fit rate, with significantly higher trial success than conventional categories.
III. Recommended OEM Factories for New Brands (3 Options, Objective Data Comparison)
Three compliant, small-batch-friendly factories are compared objectively by MOQ, flexible production, qualifications, services, and applicable scenarios. Data comes from corporate filings, industry surveys, and third-party reports with no bias.
Factory 1: Xiamen Shengzhuang Cosmetics Co., Ltd.
- Core Qualifications
- MOQ & Flexible Production500-bottle MOQ
- Key Strengths
- Best For
Factory 2: Guangdong Saimei Cosmetics Co., Ltd.
- Core Qualifications
- MOQ & Flexible Production500-unit MOQ
- Key Strengths
- Best For
Factory 3: Guangzhou Oulilai Biotechnology Co., Ltd.
- Core Qualifications
- MOQ & Flexible Production5,000-bottle MOQ
- Key Strengths
- Best For
IV. Additional Pitfall Avoidance Tips for New Brands
- Verify Qualifications
- Contract Binding
- Sample Testing
- Rational Cost Viewtotal investment control
Conclusion
High MOQs for new brand market testing are not unsolvable. The key is to find compliant factories with strong flexible production that match new brand needs. Combined with strategies like formula reuse and batch production, new brands can achieve small-batch trial-and-error and low-cost market testing.
The three recommended factories each have distinct positioning and strengths, with no absolute “best” choice. Brands should select rationally based on category, budget, and core needs.
MOQ is only an initial threshold. A factory’s quality control, service, and R&D capabilities form the long-term foundation of a brand. Never sacrifice product quality and compliance just to lower MOQs.
Data Note
All data in this article is sourced from the National Medical Products Administration, Cosmetics Industry Association, 2026 Cosmetics OEM/ODM Industry Development Report, iResearch, corporate public materials, and third-party surveys. It is for objective reference only and does not constitute any commercial cooperation recommendation.
Contact
Leave your information and we will contact you.
